SNN (Smith & Nephew) Research & Development: $296 Mil (TTM As of Dec. 2025)


SNN Smith & Nephew PLC SNN
86 GF Score
Price $30.26
GF Value $31.44
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Smith & Nephew Research & Development?

Smith & Nephew SNN +2.20% 86 Research & Development is $296 Mil as of Dec. 2025. GuruFocus rates SNN with a GF Score™ of 86/100 and a GF Value™ of $31.44 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Smith & Nephew's Research & Development for the six months ended in Dec. 2025 was $153 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $296 Mil.

Smith & Nephew  (NYSE:SNN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Smith & Nephew Research & Development Related Terms

Smith & Nephew Research & Development Historical Data

* Premium members only.

The historical data trend for Smith & Nephew's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smith & Nephew Research & Development Chart

Smith & Nephew Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 356.00 345.00 339.00 289.00 296.00

Smith & Nephew Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 173.00 137.00 152.00 143.00 153.00
SNN
86GF Score
Smith & Nephew PLC SNN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Smith & Nephew Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $296 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $296 Mil mean?
Smith & Nephew (SNN) has a Research & Development of $296 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Smith & Nephew and its competitors.
Is Smith & Nephew's Research & Development too high?
Smith & Nephew's current Research & Development is $296 Mil. Overall, Smith & Nephew has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Smith & Nephew's Research & Development compare to ABT and SYK?
Smith & Nephew's Research & Development of $296 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Smith & Nephew and its competitors. Smith & Nephew's current Research & Development is $296 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smith & Nephew stock overvalued right now?
Based on GuruFocus' analysis, Smith & Nephew (SNN) is currently considered Fairly Valued. The stock's GF Value™ is $31.44, compared to a current price of $30.26 — trading 3.8% below its estimated fair value. The current Research & Development is $296 Mil. Smith & Nephew's overall GF Score™ is 86/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Smith & Nephew (SNN), the current Research & Development is $296 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Smith & Nephew (SNN) Overvalued in 2026?

Based on GuruFocus' analysis, Smith & Nephew stock appears to be undervalued. The current stock price of $30.26 is trading 3.8% below its estimated GF Value™ of $31.44. GuruFocus considers Smith & Nephew to be Fairly Valued.

Key valuation signals for SNN:

  • Research & Development: $296 Mil
  • GF Value™: $31.44 vs. price of $30.26 (3.8% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the SNN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Smith & Nephew Business Description

Address Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
86GF Score

Get the complete analysis for SNN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$30.26
Price
$31.44
GF Value